ACCELERATING PROMISING ONCOLOGY THERAPEUTICS INTO THE CLINIC THROUGH COLLABORATIVE DRUG DEVELOPMENT
The USC Norris CCDD drug development process is uniquely structured in partnership with faculty to accelerate a rigorous review of projects. This process will be managed by the MESH Academy Business Development and Industry Relations team to ensure transparency, establish a central point of contact, and reduce redundancies and missed opportunities.
Faculty complete Intake Form. This signals the first step in the review process.
Faculty will be paired with a MESH representative to:
No cookie cutter approach – each innovation is unique and requires iterative dialogue with faculty to engage and co-create a successful path to the clinic
How to Submit a Target to CCDD:
If you have any questions or would like to discuss your target/therapeutic before submitting the intake form, please contact the MESH BDIR team at firstname.lastname@example.org.
Faculty give short presentation, followed by Q&A.
EAC will rank each project based on 7 criteria:
EAC will provide list of prioritized targets with feedback to the CCDD Leadership team.
EAC will provide list of prioritized targets to advance
For targets that are advanced, faculty will work collaboratively with:
NCCC Director provides final decision on budget requests
Approved projects typically fall into one of these categories:
The MESH BDIR team will collaborate with the faculty/project team and with potential prospective external collaborators to formulate a partnering strategy that is mutually beneficial. The focus of the partnering zone is to: